Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00843219 · ClinicalTrials.gov registry record
Motion Correction of Positron Emission Tomography (PET) Data Using Amplitude Gating
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 12
- Enrollment target
NCT00843219: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00843219 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00843219 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
Objectives: Evaluation of an amplitude based gated Positron Emission Tomography (PET) data acquisition system for all GE Discovery Positron Emission Tomography/ Computed Tomography (PET/CT) scanners.
Interventions
- PROCEDURE PET/CT Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2009-03 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00843219
The ClinicalTrials.gov registry entry for NCT00843219 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PET/CT Scan is the first listed.
NCT00843219 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00843219 about?
NCT00843219 is a clinical study titled "Motion Correction of Positron Emission Tomography (PET) Data Using Amplitude Gating". Objectives: Evaluation of an amplitude based gated Positron Emission Tomography (PET) data acquisition system for all GE Discovery Positron Emission Tomography/ Computed Tomography (PET/CT) scanners.
What is the current status of trial NCT00843219?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2009-03. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00843219?
The interventions under investigation include: PET/CT Scan (PROCEDURE).
Who is sponsoring clinical trial NCT00843219?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.